The patent of the Turku-based pharmaceutical innovation company has been granted in the USA The company is now actively looking for an international partner Nasal spray affects the function of the nasal mucosa as the virus tries to replicate in the body Turku-based drug innovation company Therapeutica Borealis Oy has been granted a patent from……

Clinical data company BCB Medical takes big steps towards internationalization The solutions of two Nordic companies have created interest in northern Europe BCB’s monitoring solutions are already being used by over 10 000 healthcare professionals. BCB Medical, the Finnish market leader in advanced software systems for gathering and analyzing clinical data, has acquired its Swedish partner……

The Happy Pro campaign, conducted for the first time in cooperation with cities in Southwest Finland, reached over four million talents from around the globe. The campaign was especially of interest to engineers with experience from fields such as AI, robotics and data science. – The attractiveness of Southwest Finland’s cities is based on an exceptionally……

Summa Equity sells antibody and antigen developer HyTest to Chines Mindray HyTest is one of the biggest IVD suppliers in the world HyTest, headquartered in Turku, has about 130 employees Summa Equity has agreed to sell HyTest to Mindray for €545 million Summa Equity has signed a definitive agreement to sell HyTest, a leading developer……

More than 100 Turku-based operators and companies have already joined Clean & Safe Turku operating model Companies could follow the model for no costs and Clean & Safe logo is awarded when the company is committing to follow the model’s requirement The marketing campaign for the operating model will be held in May-June on the……

In April, the Finnish Bioindustries Association appointed Maarit Merla as the new Board Chair. Only a few months earlier, Maarit became a Board Member of the Chemical Industry Federation of Finland. We wanted to have a closer look at who is Maarit Merla and what are her views on the Finnish drug development industry.  Presently,……

The fourth Europe Forum will be arranged in Turku, Finland, on the 25th to 27th of August 2021.  Europe Forum discussions will focus on eg. the post-pandemic reconstruction The Europe Forum is part of a wider Conference on the Future of Europe The fourth Europe Forum will be arranged in Turku, Finland, on the 25th to 27th of August 2021….…

Innovation prevents contracting of the disease and decreases the risk of falling ill seriously Nasal spray prevents and weakens the ability of the virus to enter the body and replicate itself Launching the drug on the market will, however, require the resources of an established pharmaceutical industry company and an international business scale Turku-based drug……

Werstas labs offers an outstanding working environment for young life science companies in the product development phase ProHealth Growth Programme supports healthcare companies in their business development HealthTurku cluster enables innovation synergies Werstas Labs is a co-working space in the Turku Science Park area, that offers not only standard office services, but also access to……

The appointments of Juha Laine and Timo Veromaa are part of the InFLAMES Flagship research The professors of practice will increase the societal impact and collaboration between the University and life science companies They also will help enable commercialisation of life science innovations Docent Juha Laine has been appointed as Professor of Practice in Pharmacoeconomics……